Skip to main content
OpenTrials
Completed

NCT Number: NCT03802305

Comparison of Osteocentral Versus Locoregional Anesthesia in Case of Mandibular Molar Pulpitis

The irreversible acute pulpitis is the most common emergency at the hospital during dental consultation. Pulpitis are characterized by intense and spontaneous oro-facial pains. In case of mandibular molar, the emergency treatment consists in realizing a pulpotomy (eviction of cameral pulp) under locoregional anesthesia called inferior alveolar nerve block (IANB). The latter represents a real challenge, since inflammation may decrease its action. To mitigate this deficiency and the drawbacks of the IANB (onset and duration of the anesthesia, bites risk reported with IANB) other anesthesias are proposed. In particular the computerized intraosseous technique anesthesia of which the Quicksleeper™ system is a part. However, according to the observers, a mild to severe tachycardia have been reported.

Very few valid clinical trials exists on the subject, most being realized with systems of intraosseous anesthesia other than Quicksleeper™. Therefore, the aim of this study is first to analyze the variations of the cardiovascular parameters into two groups of anesthesia: locoregional anesthesia and Quicksleeper ™ system; and then, to compare the efficiency, side effects, operating consequences of both techniques. This study should provide better data about potential risk with computerized intraosseous technique such has Quicksleeper ™ system in healthy or cardiovascular risk patient.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nantes Universitary Hospital

Nantes, Loire-Atlantique, 44093, France

About this study

When the patient arrive in the dental care center, an initial assessment is made to get the diagnosis of irreversible pulpitis:

  • Anamnesis:

acute and spontaneous oro-facial pain, pulsatile severe intensity, which could irradiate toward the ear and/or jaw, exacerbated by cold or hot.

  • Clinical exams: positive vitality tests (electric test and cold pressor test)
  • Further examination (radiography)

The inclusion and exclusion criteria will be checked and the informed consent of the patient will be taken. The patient is then randomized in one of the group (experimental or control). He will fill a questionnaire (Corah's scale) for evaluating his state of anxiety during care. A monitoring of cardiac parameters is made during the care at defined moment.

The patient evaluates his pain himself with the VAS (Visual Analog Score), before the intervention. The anesthesia is carried out by only one experimenter, with the Quickslepper™ handpiece but different specific needles.

Each patient receive 1.8 mL of 4% articaine 1:100 000 on a period of 2 minutes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • real irreversible pulpitis of a mandibular molar in dental emergency consultation at the Nantes hospital
  • Healthy patient without medical history (ASA 1), without treatment for heart rate distress (anti arrhythmic, beta-blocking drug)
  • Major and covered by the social security
  • Informed consent

Exclusion criteria

  • ASA > 1
  • Pregnant and breastfeeding women
  • Minors
  • Adults under guardianships
  • Adults deprived of freedom
  • Impossibility to obtain for informed consent
  • Allergy to anesthetic components
  • Contraindication of vasoconstrictor
  • Angle closure glaucoma
  • Pheochromocytomas
  • Bisphosphonate IV
  • Irradiated patient (upper respiratory and gastrointestinal tract cancer)
  • Contraindication with Mono-amino oxidase inhibitors
  • Acute apical periodontitis
  • Pulpitis on wisdom teeth
  • Vital teeth with fixed prosthesis
  • Active periodontal disease
  • Local anatomic difficulty
  • No reference tooth for vitality dental test

Treatment and study plan

computerized intraosseous technique (Quicksleeper™)

Device

The anesthetic solution is administered with a specific equipment allowing the injection step by step:

  • anesthesia of the interdental papilla,
  • positioning of the needle and perforating of the interdental space,
  • Injection of the solution. All of these steps are based on an adjustment of the different part of this equipment.

loco-regional anesthesia (IANB technique)

Device

The anesthetic solution is delivered by a needle near to the inferior alveolar nerve before it enters the mandibular foramen.

Primary outcomes

  1. time required (in minutes) to re-obtain the baseline cardiovascular parameters like reported before injection: expected event.

    Time frame: at day 0, from T0 minute to T14 minutes

    • 3 successive values of heart rate similar to those registered before injection.
    • 3 successive values of blood pressure (diastolic and systolic) similar to those registered before injection.

Secondary outcomes

  1. Compare the pain of the patient between the two anesthetic techniques

    Time frame: 3 days

    Scores measured with Visual Analog Score( Heft-Parker's pain assessment) (minimum score : no pain ; maximal score : maximum pain unimaginable)

  2. Compare the possible postoperative course between the 2 anesthetic techniques

    Time frame: 3 days

    The postoperative course will be evaluated using a post-operative table to be completed by the patient at Day + 1, Day + 2 and Day + 3. Collection of information by phone call to the patient. The presence or absence of the following item is measured : pain after waking up, swelling, hematoma, seepage, higher tooth sensation, bite, possibility of feeding, mouth opening limitation.

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

Comparison of the Variations of the Cardiovascular Parameters and the Efficiency of the Osteocentral Anesthesia (Quicksleeper™) and the Locoregional Anesthesia in the Case of Mandibular Pulpitis

Acronym: COQ

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Jan 14, 2019
Registry last updated
Jun 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.